Home > Insider Trading > Filing (0001140361-14-034231)

Filing Details

Accession Number:: 0001140361-14-034231
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-26 19:52:18
Reporting Period:: 2014-08-22

Filing Date:: 2014-08-26
Accepted Time:: 2014-08-26 19:52:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1416792	Relypsa Inc	RLYP	Pharmaceutical Preparations (2834)	260893742

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1455189	Lance Berman	C/O Relypsa, Inc. 700 Saginaw Drive Redwood City CA 94063	Chief Medical Officer And Svp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-08-22	13,207	$3.96	20,707	No	4	M	Direct
Common Stock	Acquisiton	2014-08-22	1,793	$7.40	22,500	No	4	M	Direct
Common Stock	Disposition	2014-08-22	15,000	$25.69	7,500	No	4	S	Direct
Common Stock	Acquisiton	2014-08-25	5,000	$7.40	12,500	No	4	M	Direct
Common Stock	Disposition	2014-08-25	5,000	$26.48	7,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-08-22	13,207	$0.00	13,207	$3.96
Common Stock	Stock Option (Right to Buy)	Disposition	2014-08-22	1,793	$0.00	1,793	$7.40
Common Stock	Stock Option (Right to Buy)	Disposition	2014-08-25	5,000	$0.00	5,000	$7.40

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
56,438	2022-09-27	No	4	M	Direct
41,810	2023-07-23	No	4	M	Direct
36,810	2023-07-23	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
Includes 7,500 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit.
This transaction was executed in multiple trades in prices ranging from $25.30 to $25.9257, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $25.78 to $26.7686, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from September 19, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from July 24, 2013 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.